(WLY) John Wiley & Sons - Overview
Stock: Journals, Books, Courseware, Assessment, Research Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.80% |
| Yield on Cost 5y | 3.29% |
| Yield CAGR 5y | 0.72% |
| Payout Consistency | 98.5% |
| Payout Ratio | 37.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.2% |
| Relative Tail Risk | -13.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.84 |
| Alpha | -38.37 |
| Character TTM | |
|---|---|
| Beta | 0.546 |
| Beta Downside | 0.413 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.76% |
| CAGR/Max DD | -0.28 |
Description: WLY John Wiley & Sons January 13, 2026
John Wiley & Sons (NYSE:WLY) is a century-old publisher that delivers data-driven content and knowledge services across science, innovation, and education in major markets including the U.S., China, the U.K., Japan, and Australia.
Its **Research** segment supplies peer-reviewed journals and related services in physical sciences, health sciences, social sciences, humanities, and life sciences, primarily to research libraries, consortia, professional societies, and via independent subscription agents.
The **Learning** segment offers print and digital textbooks, courseware, and assessment tools for students, instructors, and corporate professionals, distributing through brick-and-mortar and online retailers, college bookstores, distributors, and government agencies.
Key financial indicators (FY 2023) show revenue of roughly **$1.8 billion**, with digital products now contributing about **30 %** of total sales-a trend driven by the broader shift toward e-learning and open-access publishing. The academic publishing sector is further influenced by rising university enrollment in emerging markets and sustained U.S. federal research funding, which together support demand for Wiley’s scholarly content.
Operationally, Wiley’s operating margin has hovered near **12 %**, reflecting cost-discipline amid rising content-creation expenses and competitive pressure from large tech-enabled publishers.
For a data-centric view of how Wiley’s valuation compares to peers, you might explore the analytics platform ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 101.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.79 > 1.0 |
| NWC/Revenue: -9.55% < 20% (prev -10.86%; Δ 1.31% < -1%) |
| CFO/TA 0.09 > 3% & CFO 220.1m > Net Income 101.7m |
| Net Debt (897.2m) to EBITDA (345.1m): 2.60 < 3 |
| Current Ratio: 0.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (53.5m) vs 12m ago -2.43% < -2% |
| Gross Margin: 71.13% > 18% (prev 0.70%; Δ 7042 % > 0.5%) |
| Asset Turnover: 65.64% > 50% (prev 67.45%; Δ -1.81% > 0%) |
| Interest Coverage Ratio: 4.12 > 6 (EBITDA TTM 345.1m / Interest Expense TTM 48.0m) |
Altman Z'' 2.96
| A: -0.06 (Total Current Assets 381.2m - Total Current Liabilities 540.4m) / Total Assets 2.47b |
| B: 0.65 (Retained Earnings 1.61b / Total Assets 2.47b) |
| C: 0.08 (EBIT TTM 197.7m / Avg Total Assets 2.54b) |
| D: 0.70 (Book Value of Equity 1.21b / Total Liabilities 1.73b) |
| Altman-Z'' Score: 2.96 = A |
Beneish M -2.95
| DSRI: 1.21 (Receivables 209.7m/183.0m, Revenue 1.67b/1.76b) |
| GMI: 0.99 (GM 71.13% / 70.28%) |
| AQI: 0.99 (AQ_t 0.76 / AQ_t-1 0.76) |
| SGI: 0.95 (Revenue 1.67b / 1.76b) |
| TATA: -0.05 (NI 101.7m - CFO 220.1m) / TA 2.47b) |
| Beneish M-Score: -2.95 (Cap -4..+1) = A |
What is the price of WLY shares?
Over the past week, the price has changed by -5.43%, over one month by -5.37%, over three months by -23.04% and over the past year by -28.26%.
Is WLY a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WLY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60 | 106.4% |
| Analysts Target Price | 60 | 106.4% |
| ValueRay Target Price | 27.9 | -4% |
WLY Fundamental Data Overview February 04, 2026
P/E Forward = 10.8342
P/S = 0.9904
P/B = 2.2175
P/EG = 2.4803
Revenue TTM = 1.67b USD
EBIT TTM = 197.7m USD
EBITDA TTM = 345.1m USD
Long Term Debt = 861.7m USD (from longTermDebt, last quarter)
Short Term Debt = 26.6m USD (from shortTermDebt, last quarter)
Debt = 964.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 897.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.55b USD (1.65b + Debt 964.6m - CCE 67.4m)
Interest Coverage Ratio = 4.12 (Ebit TTM 197.7m / Interest Expense TTM 48.0m)
EV/FCF = 17.17x (Enterprise Value 2.55b / FCF TTM 148.3m)
FCF Yield = 5.82% (FCF TTM 148.3m / Enterprise Value 2.55b)
FCF Margin = 8.91% (FCF TTM 148.3m / Revenue TTM 1.67b)
Net Margin = 6.11% (Net Income TTM 101.7m / Revenue TTM 1.67b)
Gross Margin = 71.13% ((Revenue TTM 1.67b - Cost of Revenue TTM 480.9m) / Revenue TTM)
Gross Margin QoQ = 72.11% (prev 72.46%)
Tobins Q-Ratio = 1.03 (Enterprise Value 2.55b / Total Assets 2.47b)
Interest Expense / Debt = 1.21% (Interest Expense 11.7m / Debt 964.6m)
Taxrate = 22.62% (13.1m / 58.0m)
NOPAT = 153.0m (EBIT 197.7m * (1 - 22.62%))
Current Ratio = 0.71 (Total Current Assets 381.2m / Total Current Liabilities 540.4m)
Debt / Equity = 0.39 (Debt 964.6m / totalStockholderEquity, last quarter 2.47b)
Debt / EBITDA = 2.60 (Net Debt 897.2m / EBITDA 345.1m)
Debt / FCF = 6.05 (Net Debt 897.2m / FCF TTM 148.3m)
Total Stockholder Equity = 1.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.01% (Net Income 101.7m / Total Assets 2.47b)
RoE = 8.78% (Net Income TTM 101.7m / Total Stockholder Equity 1.16b)
RoCE = 9.78% (EBIT 197.7m / Capital Employed (Equity 1.16b + L.T.Debt 861.7m))
RoIC = 9.72% (NOPAT 153.0m / Invested Capital 1.57b)
WACC = 5.35% (E(1.65b)/V(2.61b) * Re(7.93%) + D(964.6m)/V(2.61b) * Rd(1.21%) * (1-Tc(0.23)))
Discount Rate = 7.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.45%
[DCF Debug] Terminal Value 84.42% ; FCFF base≈133.1m ; Y1≈112.0m ; Y5≈84.1m
Fair Price DCF = 38.07 (EV 2.56b - Net Debt 897.2m = Equity 1.67b / Shares 43.8m; r=5.90% [WACC]; 5y FCF grow -19.13% → 2.90% )
EPS Correlation: -19.21 | EPS CAGR: -50.32% | SUE: -4.0 | # QB: 0
Revenue Correlation: -87.08 | Revenue CAGR: -5.23% | SUE: 0.14 | # QB: 0
EPS current Year (2026-04-30): EPS=4.00 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+9.9% | Growth Revenue=-1.0%
EPS next Year (2027-04-30): EPS=4.40 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+10.0% | Growth Revenue=+2.3%